Your browser doesn't support javascript.
loading
Apolipoprotein B and apolipopotein A-I in vascular risk prediction - a review.
Schmidt, C; Bergstrom, G.
Afiliação
  • Bergstrom G; Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at University of Gothenburg, S-413 45 Goteborg, Sweden. caroline.schmidt@wlab.gu.se.
Curr Pharm Des ; 20(40): 6289-98, 2014.
Article em En | MEDLINE | ID: mdl-24953398
The concentration of low-density lipoprotein cholesterol has long been generally accepted as one of the strongest, independent risk factors for the development of cardiovascular disease. However, an increasing number of studies suggest that the ratio of apolipoprotein B (apoB) to apolipoprotein A-I (apoA-I) is a better risk predictor. In the present review, we focus on apoB and apoA-I as factors in predicting vascular risk in epidemiological studies only, and not in studies involving pharmaceutical intervention. The majority of studies in the present review show that apoB and the apoB/apoA-I ratio are independently and more strongly associated with vascular risk across varying age-groups and geographic regions than are conventional lipids, lipoproteins and lipid ratios.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas B / Doenças Cardiovasculares / Apolipoproteína A-I Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Ano de publicação: 2014 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apolipoproteínas B / Doenças Cardiovasculares / Apolipoproteína A-I Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Pharm Des Ano de publicação: 2014 Tipo de documento: Article